{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:05:58Z","timestamp":1790355958377,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Actelion"},{"name":"Janssen-Cilag bv"},{"name":"Mercks bv"},{"name":"St Antonius Hospital research fund"},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ferrer"},{"DOI":"10.13039\/100019832","name":"Galapagos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019832","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Corbus"},{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol Myers Squib"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is characterized by vasculopathy, inflammation, and fibrosis, and carries one of the worst prognoses if patients also develop pulmonary arterial hypertension (PAH). Although PAH is a known prognosticator, patients with SSc\u2013PAH demonstrate disproportionately high mortality, presumably due to cardiac involvement. In this cross-sectional study, the relationship between cardiac involvement revealed by cardiovascular magnetic resonance (CMR) and systemic microvascular disease severity measured with nailfold capillaromicroscopy (NCM) in patients with SSc\u2013PAH is evaluated and compared with patients with idiopathic PAH (IPAH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Patients with SSc\u2013PAH and IPAH underwent CMR, echocardiography, and NCM with post-occlusive reactivity hyperaemia (PORH) testing on the same day. CMR imaging included T2 (oedema), native, and post-contrast T1 mapping to measure the extracellular volume fraction (ECV, fibrosis) and adenosine-stress-perfusion imaging measuring the relative myocardial upslope (microvascular coronary perfusion). Measures of peripheral microvascular function were related to CMR indices of oedema, fibrosis, and myocardial perfusion. SSc-PAH patients (n = 20) had higher T2 values and a trend towards a higher ECV, compared with IPAH patients (n = 5), and a lower nailfold capillary density (NCD) and reduced capillary recruitment after PORH. NCD correlated with ECV and T2 (r = \u22120.443 and \u22120.464, respectively, P &amp;lt; 0.05 for both) and with markers of diastolic dysfunction on echocardiography. PORH testing, but not NCD, correlated with the relative myocardial upslope (r = 0.421, P &amp;lt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>SSc-PAH patients showed higher markers of cardiac fibrosis and inflammation, compared with IPAH patients. These markers correlated well with peripheral microvascular dysfunction, suggesting that SSc-driven inflammation and vasculopathy concurrently affect peripheral microcirculation and the heart. This may contribute to the disproportionate high mortality in SSc\u2013PAH.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeae001","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:52:47Z","timestamp":1704203567000},"page":"708-717","source":"Crossref","is-referenced-by-count":9,"title":["Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis\u2013related pulmonary arterial hypertension"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0510-6010","authenticated-orcid":false,"given":"Jacqueline L","family":"Vos","sequence":"first","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Geert Grooteplein 10, 6525 GA, Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M J","family":"Lemmers","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboud University Medical Center , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloua","family":"El Messaoudi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Geert Grooteplein 10, 6525 GA, Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Snoeren","sequence":"additional","affiliation":[{"name":"Department of Radiology, Radboud University Medical Center , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-8251","authenticated-orcid":false,"given":"Arie P J","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Geert Grooteplein 10, 6525 GA, Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-0143","authenticated-orcid":false,"given":"Anthonie L","family":"Duijnhouwer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Geert Grooteplein 10, 6525 GA, Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2706-9326","authenticated-orcid":false,"given":"Laura","family":"Rodwell","sequence":"additional","affiliation":[{"name":"Department of Health Evidence, Section Biostatistics, Radboud University Medical Center , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander I","family":"van Leuven","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboud University Medical Center , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-5996","authenticated-orcid":false,"given":"Martijn C","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St. Antonius Hospital , Nieuwegein , The Netherlands"},{"name":"Department of Cardiology, University Medical Center Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-9907","authenticated-orcid":false,"given":"Madelon C","family":"Vonk","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboud University Medical Center , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-6363","authenticated-orcid":false,"given":"Robin","family":"Nijveldt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Geert Grooteplein 10, 6525 GA, Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"2024042923571853700_jeae001-B1","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024042923571853700_jeae001-B2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1378\/chest.12-2396","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"144","author":"Chaisson","year":"2013","journal-title":"Chest"},{"issue":"25 Suppl","key":"2024042923571853700_jeae001-B3","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024042923571853700_jeae001-B4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.112.000008","article-title":"Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension","volume":"6","author":"Tedford","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2024042923571853700_jeae001-B5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis\u2013a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024042923571853700_jeae001-B6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijcard.2017.08.072","article-title":"Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients\u2014relationship with biochemical and echocardiography parameters","volume":"249","author":"Hrom\u00e1dka","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024042923571853700_jeae001-B7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiol.13131280","article-title":"Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis","volume":"271","author":"Thuny","year":"2014","journal-title":"Radiology"},{"key":"2024042923571853700_jeae001-B8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12872-017-0619-x","article-title":"Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria","volume":"17","author":"Mavrogeni","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"2024042923571853700_jeae001-B9","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2024042923571853700_jeae001-B10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.autrev.2017.05.019","article-title":"The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: a critical review","volume":"16","author":"Soulaidopoulos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2024042923571853700_jeae001-B11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mvr.2014.10.004","article-title":"Reduced systemic microvascular density and reactivity in individuals with early onset coronary artery disease","volume":"97","author":"Tibirica","year":"2015","journal-title":"Microvasc Res"},{"key":"2024042923571853700_jeae001-B12","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1093\/ehjci\/jeac134","article-title":"Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging","volume":"23","author":"Mavrogeni","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024042923571853700_jeae001-B13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1148\/rg.342125121","article-title":"Myocardial T1 mapping: techniques and potential applications","volume":"34","author":"Burt","year":"2014","journal-title":"Radiographics"},{"key":"2024042923571853700_jeae001-B14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024042923571853700_jeae001-B15","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"55","author":"Hundley","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2024042923571853700_jeae001-B16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12872-018-0756-x","article-title":"Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study","volume":"18","author":"Gyllenhammar","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2024042923571853700_jeae001-B17","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2024042923571853700_jeae001-B18","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","article-title":"Fast track algorithm: how to differentiate a \u201cscleroderma pattern\u201d from a \u201cnon-scleroderma pattern\u201d","volume":"18","author":"Smith","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2024042923571853700_jeae001-B19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.HYP.38.2.238","article-title":"Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction","volume":"38","author":"Serne","year":"2001","journal-title":"Hypertension"},{"key":"2024042923571853700_jeae001-B20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/ehjci\/jeac120","article-title":"Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study","volume":"24","author":"Knight","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024042923571853700_jeae001-B21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","article-title":"Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing","volume":"22","author":"Schulz-Menger","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024042923571853700_jeae001-B22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcmg.2019.07.019","article-title":"Cardiac magnetic resonance for evaluating nonculprit lesions after myocardial infarction: comparison with fractional flow reserve","volume":"13","author":"Everaars","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024042923571853700_jeae001-B23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12968-020-00683-3","article-title":"Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update","volume":"22","author":"Kawel-Boehm","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024042923571853700_jeae001-B24","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1161\/CIRCULATIONAHA.117.033147","article-title":"Right ventricular myofilament functional differences in humans with systemic sclerosis-associated versus idiopathic pulmonary arterial hypertension","volume":"137","author":"Hsu","year":"2018","journal-title":"Circulation"},{"key":"2024042923571853700_jeae001-B25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2024042923571853700_jeae001-B26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2023.01.066","article-title":"Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma","volume":"376","author":"Meloni","year":"2023","journal-title":"Int J Cardiol"},{"key":"2024042923571853700_jeae001-B27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2024042923571853700_jeae001-B28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3899\/jrheum.081088","article-title":"Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension","volume":"36","author":"Peled","year":"2009","journal-title":"J Rheumatol"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeae001\/56248879\/jeae001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/25\/5\/708\/57341562\/jeae001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/25\/5\/708\/57341562\/jeae001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T23:58:04Z","timestamp":1714435084000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/25\/5\/708\/7505494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,1,3]]},"published-print":{"date-parts":[[2024,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeae001","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,1,3]]}}}